<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 04:52:09 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</guid>
      <description><![CDATA[As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in &quot;common stock equivalents&quot;, $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3688027>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 14:19:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</link>
    </item>
    <item>
      <title>Forget Yesterday, It's All About Jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</guid>
      <description><![CDATA[Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687896>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 13:21:30 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVLT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</link>
    </item>
    <item>
      <title>Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</guid>
      <description><![CDATA[The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3686922>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 04:14:41 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</link>
    </item>
    <item>
      <title>A Busy Month For Immunogen (Part II)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3685816</guid>
      <description><![CDATA[At ASH 2009, Immunogen (IMGN) and its partners will present clinical data on three compounds: Sanofi-Aventis’ (SNY) SAR3419, Immunogen’s IMGN901 and Biotest’s BT-062.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3685816>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 21:03:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLDA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MITI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3685816</link>
    </item>
    <item>
      <title>China Will Continue To Drive The Global Economic Recovery In 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</guid>
      <description><![CDATA[China isn’t just leading the global economic recovery – it’s lapping the field.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683989>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 14:38:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GROW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</link>
    </item>
    <item>
      <title>Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</guid>
      <description><![CDATA[Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, &quot;Construction That Fueled Growth in the Sun Belt Slows&quot;:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683785>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 13:15:56 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</link>
    </item>
    <item>
      <title>Credit Market Overview:  Dec 3, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</guid>
      <description><![CDATA[The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683773>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 12:59:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</link>
    </item>
    <item>
      <title>Grab Some Northern Exposure With EWC</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</guid>
      <description><![CDATA[Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682040>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:39:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</link>
    </item>
    <item>
      <title>Unemployment Struggling To Turn A Corner As Job Losses Mount In November</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</guid>
      <description><![CDATA[U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681965>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:20:20 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</link>
    </item>
    <item>
      <title>Why Barrick Closed Their Gold Hedge</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</guid>
      <description><![CDATA[It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681409>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:15:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSRI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</link>
    </item>
    <item>
      <title>Evening Standard, London, market report column</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3685440</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dec. 3--Commodity stocks should keep rising next year, but the best is  behind the financials. &lt;/li&gt;&lt;li&gt;That's the opinion of Goldman Sachs, whose strategy suggestions for 2010  were being circulated in the City today. &lt;/li&gt;&lt;li&gt;Shares in London rose, with the FTSE putting on 30.71 points to 5358.10  as the banks bounced back from yesterday's losses.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3685440>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 18:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BHP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LYG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOVN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PSA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3685440</link>
    </item>
    <item>
      <title>St. Petersburg Times, Fla., Robert Trigaux column: Florida lags in venture capital</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3675958</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Dec. 1--Florida entrepreneurs must possess cast-iron constitutions to try building start-up companies in these economic times. &lt;/li&gt;&lt;li&gt;Ask Florida Venture Capital Forum executive director Robin Kovaleski in Tampa what the climate is like these days for venture capital funding and she alternates between &quot;tough&quot; and &quot;brutal.&quot; &lt;/li&gt;&lt;li&gt;The survey may quibble with me, but I'll add one more name, Sharklet Technologies of Alachua, as a fifth Florida company to get funding just as the second quarter ended and third quarter began.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3675958>[More...]</a>]]></description>
      <pubDate>Tue, 01 Dec 2009 16:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SRI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3675958</link>
    </item>
    <item>
      <title>Seasonal flu vaccine supplies spur worries</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3662141</guid>
      <description><![CDATA[Seasonal flu vaccine supplies spur worries<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3662141>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 15:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3662141</link>
    </item>
    <item>
      <title>New Jersey index reaches a yearly high</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3659559</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 22--The Asbury Park Press/Bloomberg 75 index reached a yearly high  last Wednesday and ended the week up .28 percent. &lt;/li&gt;&lt;li&gt;The index, made up of 75 companies either headquartered at the Shore or  with significant operations in New Jersey, was at 108.92 Friday at 5 p.m., up  .3 points. &lt;/li&gt;&lt;li&gt;The index has risen 13.1 percent since the beginning of the year.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3659559>[More...]</a>]]></description>
      <pubDate>Sun, 22 Nov 2009 21:03:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HOV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RWEOY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3659559</link>
    </item>
    <item>
      <title>Star Tribune, Minneapolis, Dick Youngblood column: A broader client base propels hot growth in sales at Minnesota Thermal Science</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3645414</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 18--Minnesota Thermal Science (MTS) is a small Plymouth company with a big-time product line: thermal-insulated containers that protect temperature-sensitive medical and biological materials for several days during shipment, even in extreme temperature fluctuations. &lt;/li&gt;&lt;li&gt;Better yet, sales since July have grown to an average of about $750,000 a month on the way to a projected 2010 total of $10 million to $12 million, said MTS President Thomas Anderson. &lt;/li&gt;&lt;li&gt;The company's original client was the U.S. military, which uses the MTS product to keep blood needed by combat casualties from spoiling under extreme heat.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3645414>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 09:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MTS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3645414</link>
    </item>
    <item>
      <title>A broader client base propels hot growth for Minnesota Thermal Science: Minnesota Thermal Science of Plymouth is broadening its customer base beyond the military.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3644978</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 18--Minnesota Thermal Science (MTS) is a small Plymouth company with a big-time product line: thermal-insulated containers that protect temperature-sensitive medical and biological materials for several days during shipment, even in extreme temperature fluctuations. &lt;/li&gt;&lt;li&gt;Better yet, sales since July have grown to an average of about $750,000 a month on the way to a projected 2010 total of $10 million to $12 million, said MTS president Thomas Anderson. &lt;/li&gt;&lt;li&gt;The company's original client was the U.S. military, which uses the MTS product to keep blood needed by combat casualties from spoiling under extreme heat.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3644978>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 02:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MTS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3644978</link>
    </item>
    <item>
      <title>FDA approves additional H1N1 vaccine</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3640702</guid>
      <description><![CDATA[FDA approves additional H1N1 vaccine<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3640702>[More...]</a>]]></description>
      <pubDate>Mon, 16 Nov 2009 19:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3640702</link>
    </item>
    <item>
      <title>Daily Mail, London, market report column</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3634659</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 13--Lansdowne Partners, one of London's largest and shrewdest hedge  funds, began the year making a mint out of betting on the hefty fall in the  Barclays' share price.  &lt;/li&gt;&lt;li&gt;Cattle genetics group Genus, famous for its Friesian bull Picston Shottle  and in which Lansdowne holds 12.4pc, fell 70p to 570p.  &lt;/li&gt;&lt;li&gt;The company, which sells semen from high  yield strains of cows and pigs to farmers, warned that the US market has  continued to deteriorate as dairy farmers trade down and pig farmers put off  investing in new animals.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3634659>[More...]</a>]]></description>
      <pubDate>Fri, 13 Nov 2009 18:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">II</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NTG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PMU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UBS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3634659</link>
    </item>
    <item>
      <title>Drug industry presses FDA to allow more online ads</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3627478</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON - As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.&lt;/li&gt;&lt;li&gt;The Food and Drug Administration will convene a two-day meeting beginning Thursday to hear the drug industry's position on Internet marketing. &lt;/li&gt;&lt;li&gt;The agency has agreed to consider developing rules for online advertising after companies complained that the current guidelines for traditional media - which require a detailed list of possible side effects - have left them hamstrung on the Web.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3627478>[More...]</a>]]></description>
      <pubDate>Wed, 11 Nov 2009 19:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3627478</link>
    </item>
    <item>
      <title>Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613879</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--Targacept Inc. posted its first quarterly profit in nearly three years yesterday, bolstered in large part by a $10 million milestone payment by AstraZeneca PLC. &lt;/li&gt;&lt;li&gt;Targacept, based in Piedmont Triad Research Park in Winston-Salem, is developing drugs based on nicotine research to treat diseases of the central nervous system. &lt;/li&gt;&lt;li&gt;The payment was the result of Targacept's research in adult attention deficit/hyperactivity disorder involving its AZD3480 drug compound, also known as TC-1734.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613879>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613879</link>
    </item>
    <item>
      <title>Rothman Research Issues Fundamental Research on Players in the Financial, Healthcare &amp;amp; Services Sectors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3671705</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;The positive economic data offset a report on new orders for long-lasting U.S. manufactured goods that unexpectedly fell in October. &lt;/li&gt;&lt;li&gt;As today's market news unfolds Rothman Research begun tracking the following companies Banco Bradesco S.A. (NYSE: BBD), Synovus Financial Corp. (NYSE: SNV), Bristol-Myers Squibb Company (NYSE: BMY), Foot Locker Inc.  (NYSE: FL), Safeway Inc. (NYSE: SWY) and Express Scripts Inc. (NASDAQ: ESRX) as they have shown remarkable correction in recent days. &lt;/li&gt;&lt;li&gt;All reports can be accessed once you register on Rothman Research by clicking on the link below:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3671705>[More...]</a>]]></description>
      <pubDate>Mon, 30 Nov 2009 11:02:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SWY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3671705</link>
    </item>
    <item>
      <title>PicksThatMove.com Announces Investment Opinion on Bristol-Myers Squibb Co., Incyte Corp., EnCana Corporation, B2Gold Corp. and Medclean Technologies Inc.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3666556</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PicksThatMove is pleased to bring investors special situation stocks   which have a high potential for price appreciation. &lt;/li&gt;&lt;li&gt;Bristol-Myers Squibb Co. (NYSE: BMY), $25.53, +$0.37, 1.47%, is   trading with gains today reaching a high of $25.75, with 24 million   shares traded. &lt;/li&gt;&lt;li&gt;Last company announcement, released mid month, confirmed third   quarter financial results with cash flow of US$2.1 billion and operating   earnings of $775 million, down 26 and 46 percent respectively compared   to the third quarter of last year.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3666556>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ECA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCLN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3666556</link>
    </item>
    <item>
      <title>Bristol-Myers Squibb Announces Split-Off of Mead Johnson</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3637020</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bristol-Myers   Squibb Company (NYSE: BMY) today announced it will split off its   holdings in Mead Johnson Nutrition Company. &lt;/li&gt;&lt;li&gt;In the exchange offer, Bristol-Myers Squibb shareholders can exchange   some, none or all of their shares of Bristol-Myers Squibb common stock   for shares of Mead Johnson common stock. &lt;/li&gt;&lt;li&gt;Such forward-looking   statements are based on current expectations and involve inherent risks   and uncertainties, including factors that could delay, divert or change   any of them, and could cause actual outcomes and results to differ   materially from current expectations.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3637020>[More...]</a>]]></description>
      <pubDate>Mon, 16 Nov 2009 04:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MJN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3637020</link>
    </item>
    <item>
      <title>AMRI Announces Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3618123</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Financial highlights for the quarter and other significant events   include:&lt;/li&gt;&lt;li&gt;Total revenue for the third quarter of 2009 was $47.7 million, a   decrease of 22% compared to total revenue of $61.4 million reported in   the third quarter of 2008.&lt;/li&gt;&lt;li&gt;Total contract revenue encompasses revenue from AMRI's   Discovery Services, Development and Small Scale Manufacturing, and Large   Scale Manufacturing business components.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3618123>[More...]</a>]]></description>
      <pubDate>Mon, 09 Nov 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMRI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RDY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3618123</link>
    </item>
    <item>
      <title>Merck and Schering-Plough to Complete Merger Today</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601769</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Merck &amp; Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE:   SGP) today announced that they will complete their merger shortly   after 4:00PM ET today. &lt;/li&gt;&lt;li&gt;As previously announced, Schering-Plough   will change its name to Merck and its common stock will trade under the   ticker symbol &quot;MRK&quot; on the New York Stock Exchange.&lt;/li&gt;&lt;li&gt;The following factors, among others, could cause actual results to   differ from those set forth in the forward-looking statements: the   possibility that the expected synergies from the merger of Merck and   Schering-Plough will not be realized, or will not be realized within the   expected time period, due to, among other things, the impact of   pharmaceutical industry regulation and pending legislation that could   affect the pharmaceutical industry; the risk that the businesses will   not be integrated successfully; disruption from the merger making it   more difficult to maintain business and operational relationships;   Merck's ability to accurately predict future market conditions;   dependence on the effectiveness of Merck's patents and other protections   for innovative products; the risk of new and changing regulation and   health policies in the U.S. and internationally and the exposure to   litigation and/or regulatory actions.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601769>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 15:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601769</link>
    </item>
    <item>
      <title>Ligand to Acquire Metabasis for Cash and Contingent Value Rights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3582276</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Metabasis   Therapeutics, Inc. (NASDAQ: MBRX) announced today they have entered into   a definitive merger agreement under which Ligand will acquire all of the   outstanding shares of Metabasis.&lt;/li&gt;&lt;li&gt;The CVRs will entitle   Metabasis stockholders to cash payments as frequently as every six   months as cash is received by Ligand from proceeds from the sale or   partnering of any of the Metabasis drug development programs, among   other triggering events. &lt;/li&gt;&lt;li&gt;Such forward-looking statements   include, but are not limited to, the expected timing of closing the   merger, statements about the benefits of the transaction between Ligand   and Metabasis, including future financial and operating results and   revenue potential, the expected effect of the merger on Ligand's   operating cash burn rate, the possibility of payments being made under   the CVR agreements, the combined entity's plans, objectives,   expectations and intentions and other statements that are not historical   facts.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3582276>[More...]</a>]]></description>
      <pubDate>Tue, 27 Oct 2009 11:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MBRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3582276</link>
    </item>
    <item>
      <title>RidgewaterEquity.Com Free Fundamental Sector &amp;Amp; Market Research on OLN, LXK, SGP, MMM, LYG and STSI</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3578842</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;RidgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers and financial pundits worldwide have to say about any particular large cap stocks in any given financial environment. &lt;/li&gt;&lt;li&gt;Once you sign up as a free member you will have free unlimited access to all our reports, research tools and more.&lt;/li&gt;&lt;li&gt;We have recently begun in-depth analysis of the following equities &amp;amp; their respective sectors:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3578842>[More...]</a>]]></description>
      <pubDate>Mon, 26 Oct 2009 12:04:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">LXK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LYG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OLN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STSI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3578842</link>
    </item>
    <item>
      <title>Procter &amp;Amp; Gamble Co. Up 13% Since Added to Galtstock Long Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3576305</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Subscribers to galtstock.com &quot;Long-Term Portfolio&quot; service (membership) invest in solid long-term holdings. &lt;/li&gt;&lt;li&gt;Other stocks in our portfolio are Procter &amp;amp; Gamble (NYSE: PG), Coca-Cola (NYSE: KO), GlaxoSmithKline (NYSE: GSK), and McDonald's Corp. (NYSE: MCD).&lt;/li&gt;&lt;li&gt;To sign up for Galt's Long-Term Portfolio service, please visit the website at http://www.galtstock.com/Long-Term-Portfolio.html with secure check out.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3576305>[More...]</a>]]></description>
      <pubDate>Fri, 23 Oct 2009 21:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3576305</link>
    </item>
    <item>
      <title>Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Bristol-Myers   Squibb Company (NYSE:BMY) today reported strong sales and earnings   growth for the third quarter 2009.&lt;/li&gt;&lt;li&gt;&quot;The performance in the third quarter of 2009 clearly shows the results   of our outstanding business performance, disciplined financial   management and overall strategic execution,&quot; said James   M. Cornelius, chairman and chief executive officer. &lt;/li&gt;&lt;li&gt;Third Quarter Performance                                                                                                                2009        2008        Change   Net Sales                                           $  5,487    $  5,254    4%       Net Earnings from Continuing Operations             $  966      $  588      64%      GAAP Diluted EPS from Continuing Operations            0.48        0.29     66%      Non-GAAP Diluted EPS from Continuing Operations        0.52        0.45     16%      ($ amounts in millions, except per share amounts)&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571548>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MJN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571548</link>
    </item>
    <item>
      <title>Mead Johnson Reports Solid Third Quarter Results; Narrows Full-Year 2009 Guidance to Top End of Range</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3571551</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Mead Johnson Nutrition Company (NYSE: MJN) announced today its financial   results for the third quarter ended Sept. 30, 2009, including:&lt;/li&gt;&lt;li&gt;GAAP earnings of $0.48 per diluted share, down from $0.61 a year ago,   reflecting the impact of higher interest expense and shares   outstanding in 2009.&lt;/li&gt;&lt;li&gt;Third Quarter GAAP Results Net sales for the third quarter   of 2009 totaled $699.8 million, down 6 percent from $742.8 million a   year-ago.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3571551>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MJN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3571551</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Dec 02  Filed by: SOFFER ROBERT M (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681424</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681424>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:27:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681424</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Dec 01  Filed by: SOFFER ROBERT M (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3677487</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3677487>[More...]</a>]]></description>
      <pubDate>Tue, 01 Dec 2009 20:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3677487</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Nov 24  Filed by: HOWEY GREGORY B (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3665284</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3665284>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 16:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3665284</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Nov 23  Filed by: Pelletier Ronald J. (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3663058</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3663058>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 20:19:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3663058</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Nov 23  Filed by: SOFFER ROBERT M (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661693</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661693>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 16:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661693</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Nov 17  Filed by: SOFFER ROBERT M (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3646333</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3646333>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 16:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3646333</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Nov 12  Filed by: MIDDLETON PAUL B (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3633547</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3633547>[More...]</a>]]></description>
      <pubDate>Fri, 13 Nov 2009 15:19:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3633547</link>
    </item>
    <item>
      <title>Form  4          ROGERS CORP               For: Nov 11  Filed by: SOFFER ROBERT M (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3629718</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3629718>[More...]</a>]]></description>
      <pubDate>Thu, 12 Nov 2009 17:34:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3629718</link>
    </item>
    <item>
      <title>Form  4          MCGRATH EUGENE R          For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608279</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608279>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 22:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608279</link>
    </item>
    <item>
      <title>Form  4          Colligan Thomas J         For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608273</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608273>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 22:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608273</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=BMY,GSK,ROG,SGP," rel="self" type="application/rss+xml" />
  </channel>
</rss>